Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Neoplasms, Unknown Primary × Cisplatin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Carcinoma, Non-Small-Cell Lung 130 Head and Neck Neoplasms 60 Squamous Cell Carcinoma of Head and Neck 57 Lung Neoplasms 46 Stomach Neoplasms 43 Esophageal Neoplasms 32 Neoplasms 30 Urinary Bladder Neoplasms 29 Uterine Cervical Neoplasms 28 Carcinoma, Squamous Cell 24 Parkinson Disease 4, Autosomal Dominant Lewy Body 23 Neoplasm Metastasis 22 Small Cell Lung Carcinoma 21 Breast Neoplasms 18 Cholangiocarcinoma 17 Carcinoma 14 Mesothelioma, Malignant 13 Adenocarcinoma Of Esophagus 13 Triple Negative Breast Neoplasms 11 Pancreatic Neoplasms 11 Ovarian Neoplasms 11 Adenocarcinoma 11 Mesothelioma 10 Carcinoma, Transitional Cell 10 Biliary Tract Neoplasms 10 Oropharyngeal Neoplasms 9 Gallbladder Neoplasms 9 Fallopian Tube Neoplasms 9 Esophageal Squamous Cell Carcinoma 9 Tongue Neoplasms 7

Interventions

Paclitaxel 6 Carboplatin 6 Gemcitabine 3 Irinotecan 2 Erlotinib Hydrochloride 2 Capecitabine 2 Bevacizumab 2 sintilimab 1 pertuzumab 1 pemigatinib 1 olaparib 1 ivosidenib 1 ipatasertib 1 etoposide phosphate 1 erythromycin propionate-N-acetylcysteinate 1 entrectinib 1 cobimetinib 1 belinostat 1 atezolizumab 1 antineoplaston AS 2-1 1 antineoplaston A10 1 alectinib 1 Vemurafenib 1 Oxaliplatin 1 HhAntag691 1 Everolimus 1 Etoposide 1 Cisplatin 1 CP protocol 1 Albumin-Bound Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03498521 2025-11-19

CUPISCO

Hoffmann-La Roche

Phase 2 Completed

529 enrolled 16 charts

Neoplasms, Unknown Primary

Data powered by HemOnc (CC BY 4.0) Colophon ⚡